Cargando…

Missed irradiation of cellular blood components for vulnerable patients: Insights from 10 years of SHOT data

BACKGROUND: Irradiation of cellular blood components is recommended for patients at risk of transfusion‐associated graft‐vs‐host disease (TA‐GvHD). Prestorage leucodepletion (LD) of blood components is standard in the UK since 1999. STUDY DESIGN AND METHODS: Analysis of 10 years' reports from U...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elliot, Johnathon, Narayan, Shruthi, Poles, Debbi, Tuckley, Victoria, Bolton‐Maggs, Paula H. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Transfusion Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894557/ https://www.ncbi.nlm.nih.gov/pubmed/33219533 http://dx.doi.org/10.1111/trf.16189

Ejemplares similares

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Association between maternal haemoglobin and stillbirth: a cohort study among a multi‐ethnic population in England
por: Nair, Manisha, et al.
Publicado: (2017)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation
por: Oud, Josine A., et al.
Publicado: (2021)

International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn
por: Lieberman, Lani, et al.
Publicado: (2022)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components
por: Snyder, Edward L., et al.
Publicado: (2022)

Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
por: Bolton-Maggs, Paula H B, et al.
Publicado: (2013)

Clinical practice of transfusion medicine
Publicado: (1996)

Hemoterapia / Alejandro Benjamín Miroli ; prol. de Vicente Federico del Giudice
por: Miroli, Alejandro Benjamín

Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells
por: Cho, Hee Soon, et al.
Publicado: (2011)

Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital
por: Hassall, Oliver, et al.
Publicado: (2009)

Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen– and antibody to hepatitis B core antigen–positive donor
por: Blaich, Annette, et al.
Publicado: (2012)

Increased risk of volume overload with plasma compared with four‐factor prothrombin complex concentrate for urgent vitamin K antagonist reversal
por: Refaai, Majed A., et al.
Publicado: (2015)

Cost implications of implementation of pathogen-inactivated platelets
por: McCullough, Jeffrey, et al.
Publicado: (2015)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

Past and present of hepatitis E in the Netherlands
por: Hogema, Boris M, et al.
Publicado: (2014)

Pediatric blood transfusion practices at a regional referral hospital in Kenya
por: Nabwera, Helen M., et al.
Publicado: (2016)

Establishing a perinatal red blood cell transfusion risk evaluation model for obstetric patients: a retrospective cohort study
por: Xing, Zhun, et al.
Publicado: (2019)

The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions
por: Netelenbos, Tanja, et al.
Publicado: (2018)

COVID-19 and the Coombs test
por: Hendrickson, Jeanne E., et al.
Publicado: (2020)

Washing or filtering of blood products does not improve outcome in a rat model of trauma and multiple transfusion
por: Wirtz, Mathijs R., et al.
Publicado: (2018)

The assessment of platelet function by thromboelastometry as a point‐of‐care test to guide Intercept‐treated platelet support in hemato‐oncological patients and hematopoietic stem cell transplantation recipients
por: Leitner, Gerda C., et al.
Publicado: (2020)

Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study
por: Wallenhorst, Christopher, et al.
Publicado: (2020)

Phased implementation of pathogen‐reduced platelets in a health system facilitates increased manufacturing at the blood center
por: Allen, Elizabeth S., et al.
Publicado: (2019)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta‐analyses
por: da Luz, Luis Teodoro, et al.
Publicado: (2019)

Red blood cell transfusion results in adhesion of neutrophils in human endotoxemia and in critically ill patients with sepsis
por: van Hezel, Maike E., et al.
Publicado: (2019)

Elicitation of prior probability distributions for a proposed Bayesian randomized clinical trial of whole blood for trauma resuscitation
por: Jansen, Jan O., et al.
Publicado: (2020)

Volume incompliance and transfusion are essential for transfusion‐associated circulatory overload: a novel animal model
por: Klanderman, Robert B., et al.
Publicado: (2019)

Efficacy of prehospital administration of fibrinogen concentrate in trauma patients bleeding or presumed to bleed (FIinTIC): A multicentre, double-blind, placebo-controlled, randomised pilot study
por: Ziegler, Bernhard, et al.
Publicado: (2021)

Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands
por: Luken, Jessie S., et al.
Publicado: (2021)

National level adjustments to the challenges of the SARS‐CoV2 pandemic on blood banking operations
por: Matusovits, Andrea, et al.
Publicado: (2021)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Chewing the fat on TRALI
por: Cleary, Simon J., et al.
Publicado: (2021)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial
por: Gamberini, Maria Rita, et al.
Publicado: (2021)

Association between renal failure and red blood cell alloimmunization among newly transfused patients
por: Oud, Josine A., et al.
Publicado: (2020)

Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage
por: Uter, Stacey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jgf5k11d3i7adiqf7l8tna6krm